Building the Evidence Base for Treatment of Chronic Subdural Hematoma

Ng S. , Boetto J. , Huguet H. , Roche P.H. , Fuentes S. , Lonjon M. , Litrico S. , Barbanel A.M. , Sabatier P. , Bauchet L. , Chevassus H. , and Lonjon N. (2021). Corticosteroids as an adjuvant treatment to surgery in chronic subdural hematomas: A multicenter double-blind randomized placebo-controlled trial. J Neurotrauma [Epub ahead of print; doi: 10.1089/neu.2020.7560.]

Edlmann E. , Whitfield P. , Kolias A.G. , and Hutchinson P.J. (2021). Pathogenesis of chronic subdural haematoma: A cohort evidencing de novo and transformational origins. J Neurotrauma [Epub ahead of print; doi: 10.1089/neu.2020.7574.]

Holl D.C. , Volovici V. , Dirven C.M.F. , van Kooten F. , Miah I.P. , Jellema K. , Peul W.C. , van der Gaag N.A. , Kho K.H. , den Hertog H.M. , Dammers R. , and Lingsma H.F. (2019). Corticosteroid treatment compared with surgery in chronic subdural hematoma: A systematic review and meta-analysis. Acta Neurochir (Wien). 161, 1231–1242.

Miah I.P. , Herklots M. , Roks G. , Peul W.C. , Walchenbach R. , Dammers R. , Lingsma J.F. , den Hertog H.M. , Jellema K. , and Van der Gaag N.A. (2020). Dexamethasone therapy in symptomatic chronic subdural hematoma (DECSA-R): A retrospective evaluation of initial corticosteroid therapy versus primary surgery. J Neurotrauma, 37, 366–372.

Lodewijkx R. , Holl D.C. , Slot K.M. , Volovici V. , Dirven C.M.F. , Dammers R. , Vandertop W.P. , and Verbaan D. (2021). The effect of steroids as an adjunct to surgical treatment in patients with chronic subdural hematoma. J Neurotrauma [Epub ahead of print; doi: 10.1089/neu.2020.7564.]

Landis S.C. , Amara S.G. , Asadullah K. , Austin C.P. , Blumenstein R. , Bradley E.W. , Crystal R.G. , Darnell R.B. , Ferrante R.J. , Fillit H. , Finkelstein R. , Fisher M , Gendelman H.E. , Golub R.M. , Goudreau J.L. , Gross R.A. , Gubitz A.K. , Hesterlee S.E. , Howells D.W. , Huguenard J. , Kelner K. , Koroshetz W. , Krainc D. , Lazic S.E. , Levine M.S. , Macleod M.R. , McCall J.M. , Moxley R.T. 3 rd Narasimhan , K., Noble L.J. , Perrin S. , Porter J.D. , Steward O. , Unger E. , Utz U. , and Silberberg S.D. (2012). A call for transparent reporting to optimize the predictive value of preclinical research. Nature, 490, 187–191.

Hutchinson P.J. , Edlmann E. , Bulters D ,. Zolnourian A. , Holton P. , Suttner N. , Agyemang K. , Thomson S. , Anderson I.A. , Al-Tamimi Y.Z. , Henderson D. , Whitfield P.C. , Gherle M. , Brennan P.M. , Allison A. , Thelin E.P. , Tarantino S. , Pantaleo B. , Caldwell K. , Davis-Wilkie C. , Mee H. , Warburton E.A. , Barton G. , Chari A. , Marcus H.J. , King A.T. , Belli A. , Myint P.K. , Wilkinson I. , Santarius T. , Turner C. , Bond S. , and Kolias A.G. ; British Neurosurgical Trainee Research Collaborative; Dex-CSDH Trial Collaborators. (2020). Trial of dexamethasone for chronic subdural hematoma. N Engl J Med, 383, 2616–2627.